Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Recruiting

• Conditions: Breast Cancer; Lung Cancer (Diagnosis); Prostate Cancer

• Registration Number: NCT07231159
• Lead Sponsor: AdventHealth

Brief Summary

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-09
• Study First Submitted: 2025-11-14
• Study First Submitted QC: 2025-11-14
• Last Update Submitted: 2025-11-14
• Study Start: 2025-11-17
• Study First Posted: 2025-11-17
• Last Update Posted: 2025-11-17
• Primary Completion: 2026-08-30
• Study Completion: 2026-08-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Adult aged 18 or older

2. Seeking care at a CRS or emergency department

3. Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below:

   1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
   2. Breast cancer: Women aged 40 to 74 years
   3. Prostate cancer: Men aged 55 to 69 years

4. Receives a positive screening result for lung, breast, and/or prostate cancer at a study site

Exclusion Criteria

1. Displays behavior disruptive to other patients or staff
2. Refusal to accept screening for breast, lung, and/or prostate cancers

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,	From enrollment to the end of the 3 month follow-up for a total of 12 months	Reach will assess the percentage and characteristics of patients screened or excluded, as well as participant versus non-participant profiles.; Effectiveness will measure the proportion of positive screens referred for confirmatory diagnostics and compare screening rates to Healthy People 2030 goals.; Adoption will track provider education on breast, lung, and prostate cancer screening guidelines, uptake of screening practices, and staff engagement with navigation programs.; Implementation will evaluate referrals to navigation, screening rates, and for positive screens: referral time, diagnostic barriers, treatment uptake, and clinical trial screening.; Maintenance will examine primary outcomes at three months, progress toward HP2030 goals, attrition rates, and differences by patient characteristics.

Secondary Outcome Measures

Name	Time	Method
Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L)	From enrollment to the end of the 3 month follow-up for a total of 12 months	A 26-item scale to assess satisfaction with the navigation program on a scale of 3 (Very satisfied) to 1 (Not Satisfied)
PROMIS Global Health (HR-QoL) scale	From enrollment to the end of the 3 month follow-up for a total of 12 months	A 10-item scale to assess physical, mental, and social health on a scale of 5 (Excellent) to 1 (Poor), ability to carry out everyday activities on a scale of 5 (Completely) to 1 (Not at all), emotional problems on a scale of 5 (Never) to 1 (Always), fatigue on a scale of 5 (None) to 1 (Very severe), and pain on a scale of 0 (No pain) to 10 (Worst imaginable pain)

Trial Locations

Locations (1)

Adventhealth; 🇺🇸 Orlando, Florida, United States